Consciousness makes sense in the light of evolution.

I believe consciousness is a property of advanced nervous systems, and as such a product of evolution. Thus, to understand consciousness we need to describe the trajectory leading to its evolution and the selective advantages conferred. A deeper understanding of the neurology would be a significant contribution, but other advanced functions, such as hearing and vision, are explained with a comparable lack of detailed knowledge of the brain processes responsible.

Describing and explaining consciousness.

Consciousness is a property of advanced brains and as such a biological feature. Explaining biological features is somewhat different from explaining physical phenomena; in the former case, the key is to first define its functional role (the reason why it was selected) and then to outline the evolutionary trajectory leading to its presence. In the case of consciousness, there are reasonable models for both.

An Attempt to Explain Visual Aesthetic Appreciation.

We suggest an evolutionary based explanation for why humans are preoccupied with aesthetic aspects of visual input. Briefly, humans evolved to be swayed by positive and negative feelings in the form of rewards and punishments, and to pursue situations that induce rewards, even when the feeling is not sufficiently strong to be recognized as a reward. The brain is designed to offer rewards when a person focuses on certain types of visual stimuli.

Viruses belonging to Anelloviridae or Circoviridae as a possible cause of chronic fatigue.

Chronic fatigue often starts with an acute viral infection-as witnessed in the case of SARS-CoV-2-but indirect consequences of these infections are presumably the actual cause of the condition. As recently reviewed in this journal, the culprit could be a virus already present in the patient. The review covers several types of viruses, but concludes that the question is still open.

A possible effect of montelukast on neurological aging examined by the use of register data.

Background The leukotriene receptor antagonist montelukast has been shown to rejuvenate aged brains in rats; however, data on humans are still scarce. Objective To investigate if montelukast may alleviate degenerative neurological changes using a register data. Setting Norwegian registry data analyses.